KALA - Kala Pharmaceuticals' (KALA) CEO Mark Iwicki on Q2 2019 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q2 2019 Earnings Conference Call
August 6, 2019, 8:00 am ET
Company Participants
Mary Reumuth - CFO
Mark Iwicki - Chairman, President & CEO
Kim Brazzell - CMO
Todd Bazemore - COO
Conference Call Participants
Biren Amin - Jefferies
Esther Rajavelu - Oppenheimer
Yi Chen - H.C. Wainwright
Presentation
Operator
Good morning, and welcome to Kala Pharmaceuticals Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, a Q&A session will be held. As a reminder, this call is being recorded.